Neuroprotective Effects of Resveratrol Against Aβ Administration in Rats are Improved by Lipid-Core Nanocapsules

The rat brain in stereotaxic coordinates

Palkovits, M. (1983) · Neuropeptides · doi:10.1016/0143-4179(83)90049-5 · Cited by 28,959 · see citing works

The Rat Brain in Stereotaxic Coordinates

Paxinos, G., & Watson, C. (1983) · Elsevier eBooks · doi:10.1016/c2009-0-63235-9 · Cited by 28,585 · see citing works

Resveratrol improves health and survival of mice on a high-calorie diet

Baur, J. A., Pearson, K. J., Price, N. L., Jamieson, H. A., Lerin, C., Kalra, A., Prabhu, V. V., Allard, J. S., Lopez-Lluch, G., Lewis, K., et al. (2006) · Nature · doi:10.1038/nature05354 · Cited by 4,290 · see citing works

Therapeutic potential of resveratrol: the in vivo evidence

Baur, J. A., & Sinclair, D. A. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2060 · Cited by 3,958 · see citing works

Biodegradable polymeric nanoparticles as drug delivery devices

Soppimath, K. S., Aminabhavi, T. M., Kulkarni, A. R., & Rudzinski, W. E. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(00)00339-4 · Cited by 3,549 · see citing works

A new one-trial test for neurobiological studies of memory in rats. 1: behavioral data

Ennaceur, A., & Delacour, J. (1988) · Behavioural Brain Research · doi:10.1016/0166-4328(88)90157-x · Cited by 3,223 · see citing works

Pathways towards and Away from Alzheimer’s Disease

Mattson, M. P. (2004) · Nature · doi:10.1038/nature02621 · Cited by 3,052 · see citing works

The blood-brain barrier: Bottleneck in brain drug development

Pardridge, W. M. (2005) · NeuroRX · doi:10.1602/neurorx.2.1.3 · Cited by 2,798 · see citing works

Wnt signaling: a common theme in animal development

Cadigan, K. M., & Nusse, R. (1997) · Genes & Development · doi:10.1101/gad.11.24.3286 · Cited by 2,567 · see citing works

Control of β-Catenin Phosphorylation/Degradation by a Dual-Kinase Mechanism

Liu, C., Li, Y., Semënov, M. V., Han, C., Baeg, G., Tan, Y., Zhang, Z., Lin, X., & He, X. (2002) · Cell · doi:10.1016/s0092-8674(02)00685-2 · Cited by 2,066 · see citing works

Biodegradable nanoparticles for drug delivery and targeting

Hans, M. L., & Lowman, A. M. (2002) · Current Opinion in Solid State and Materials Science · doi:10.1016/s1359-0286(02)00117-1 · Cited by 1,324 · see citing works

Object recognition in rats and mice: a one-trial non-matching-to-sample learning task to study 'recognition memory'

Bevins, R. A., & Besheer, J. (2006) · Nature Protocols · doi:10.1038/nprot.2006.205 · Cited by 1,278 · see citing works

Risk Factors for Alzheimer's Disease: A Prospective Analysis from the Canadian Study of Health and Aging

Lindsay, J. (2002) · American Journal of Epidemiology · doi:10.1093/aje/kwf074 · Cited by 1,261 · see citing works

Deciphering the Molecular Basis of Memory Failure in Alzheimer's Disease

Walsh, D. M., & Selkoe, D. J. (2004) · Neuron · doi:10.1016/j.neuron.2004.09.010 · Cited by 1,207 · see citing works

Review of the folin phenol protein quantitation method of lowry, rosebrough, farr and randall

Peterson, G. L. (1979) · Analytical Biochemistry · doi:10.1016/0003-2697(79)90222-7 · Cited by 1,147 · see citing works

Bioavailability of resveratrol

Walle, T. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05842.x · Cited by 1,051 · see citing works

Hippocampal synaptic loss in early Alzheimer's disease and mild cognitive impairment

Scheff, S. W., Price, D. A., Schmitt, F. A., & Mufson, E. J. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.09.012 · Cited by 1,017 · see citing works

Neurotoxicity of Amyloid  -Protein: Synaptic and Network Dysfunction

Mucke, L., & Selkoe, D. J. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006338 · Cited by 1,000 · see citing works

Resveratrol Promotes Clearance of Alzheimer's Disease Amyloid-β Peptides

Marambaud, P., Zhao, H., & Davies, P. J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m508246200 · Cited by 750 · see citing works

Axonal Remodeling and Synaptic Differentiation in the Cerebellum Is Regulated by WNT-7a Signaling

Hall, A. C., Lucas, F. R., & Salinas, P. C. (2000) · Cell · doi:10.1016/s0092-8674(00)80689-3 · Cited by 687 · see citing works

Metabolism and bioavailability oftrans-resveratrol

Wenzel, E., & Somoza, V. (2005) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200500010 · Cited by 677 · see citing works

AMP-activated Protein Kinase Signaling Activation by Resveratrol Modulates Amyloid-β Peptide Metabolism

Vingtdeux, V., Giliberto, L., Zhao, H., Chandakkar, P., Wu, Q., Simon, J. E., Janle, E. M., Lobo, J., Ferruzzi, M. G., Davies, P. J., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.060061 · Cited by 648 · see citing works

The value of spontaneous alternation behavior (SAB) as a test of retention in pharmacological investigations of memory

Hughes, R. N. (2004) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2004.06.006 · Cited by 641 · cited 1× · see citing works

A local Wnt-3a signal is required for development of the mammalian hippocampus

Lee, S. M. K., Tole, S., Grove, E. A., & McMahon, A. P. (2000) · Development · doi:10.1242/dev.127.3.457 · Cited by 636 · see citing works

Administration of resveratrol: What formulation solutions to bioavailability limitations?

Amri, A., Chaumeil, J. C., Sfar, S., & Charrueau, C. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.09.083 · Cited by 622 · see citing works

Object recognition memory and the rodent hippocampus

Broadbent, N. J., Gaskin, S., Squire, L. R., & Clark, R. E. (2010) · Learning & Memory · doi:10.1101/lm.1650110 · Cited by 568 · see citing works

Resveratrol: A multitargeted agent for age-associated chronic diseases

Harikumar, K. B., & Aggarwal, B. B. (2008) · Cell Cycle · doi:10.4161/cc.7.8.5740 · Cited by 552 · see citing works

Passage of peptides through the blood-brain barrier with colloidal polymer particles (nanoparticles)

Kreuter, J., Alyautdin, R. N., Kharkevich, D. A., & Aa, I. (1995) · Brain Research · doi:10.1016/0006-8993(95)00023-j · Cited by 538 · see citing works

Wine consumption and dementia in the elderly: a prospective community study in the Bordeaux area.

Orgogozo, J. M., Dartigues, J. F., Lafont, S., Letenneur, L., Commenges, D., Salamon, R., Renaud, S., & Breteler, M. M. B. (1997) · PubMed · Cited by 525 · see citing works

Significant Transport of Doxorubicin into the Brain with Polysorbate 80-Coated Nanoparticles

Gulyaev, A. E., Gelperina, S. E., Skidan, I. N., Antropov, A. S., Kivman, G. Y., & Kreuter, J. (1999) · Pharmaceutical Research · doi:10.1023/a:1018983904537 · Cited by 521 · see citing works

Resolving controversies on the path to Alzheimer's therapeutics

Selkoe, D. J. (2011) · Nature Medicine · doi:10.1038/nm.2460 · Cited by 494 · see citing works

Dietary supplementation with resveratrol reduces plaque pathology in a transgenic model of Alzheimer's disease

Karuppagounder, S. S., Pinto, J. T., Xu, H., Chen, H., Beal, M. F., & Gibson, G. E. (2008) · Neurochemistry International · doi:10.1016/j.neuint.2008.10.008 · Cited by 488 · see citing works

Small assemblies of unmodified amyloid $beta;-protein are the proximate neurotoxin in Alzheimer?s disease

Klein, W. L., Stine, W. B., & Teplow, D. B. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.02.010 · Cited by 487 · see citing works

Cancer chemopreventive and therapeutic potential of resveratrol: Mechanistic perspectives

Kundu, J. K., & Surh, Y. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.03.057 · Cited by 472 · see citing works

Albumin nanoparticles targeted with Apo E enter the CNS by transcytosis and are delivered to neurones

Zensi, A., Begley, D., Pontikis, C., Legros, C., Mihoreanu, L., Wagner, S., Büchel, C., von Briesen, H., & Kreuter, J. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.03.002 · Cited by 438 · see citing works

Resveratrol Mitigates Lipopolysaccharide- and Aβ-Mediated Microglial Inflammation by Inhibiting the TLR4/NF-Κb/STAT Signaling cascade

Capiralla, H., Vingtdeux, V., Zhao, H., Sankowski, R., Al‐Abed, Y., Davies, P., & Marambaud, P. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07594.x · Cited by 426 · see citing works

Hippocampus development and generation of dentate gyrus granule cells is regulated by LEF1

Galcerán, J., Miyashita-Lin, E. M., Devaney, E. J., Rubenstein, J. L. R., & Grosschedl, R. (2000) · Development · doi:10.1242/dev.127.3.469 · Cited by 399 · see citing works

Astrocytes are important mediators of Aβ-induced neurotoxicity and tau phosphorylation in primary culture

Garwood, C. J., Pooler, A. M., Atherton, J., Hanger, D. P., & Noble, W. (2011) · Cell Death & Disease · doi:10.1038/cddis.2011.50 · Cited by 379 · see citing works

Adenosine A2AReceptor Blockade Prevents Synaptotoxicity and Memory Dysfunction Caused by β-Amyloid Peptides via p38 Mitogen-Activated Protein Kinase Pathway

Canas, P. M., Porciúncula, L. O., Cunha, G. M. A., Silva, C. G., Machado, N. J., Oliveira, J. M. A., Oliveira, C. R., & Cunha, R. A. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.3728-09.2009 · Cited by 358 · see citing works

Delivery of Loperamide Across the Blood-Brain Barrier with Polysorbate 80-Coated Polybutylcyanoacrylate Nanoparticles

Alyautdin, R. N., Petrov, V. E., Langer, K., Berthold, A., Kharkevich, D. A., & Kreuter, J. (1997) · Pharmaceutical Research · doi:10.1023/a:1012098005098 · Cited by 352 · see citing works

Resveratrol—A boon for treating Alzheimer's disease?

Anekonda, T. S. (2006) · Brain Research Reviews · doi:10.1016/j.brainresrev.2006.04.004 · Cited by 341 · see citing works

Soluble protein oligomers as emerging toxins in Alzheimer’s and other amyloid diseases

Ferreira, S. T., Vieira, M. N. N., & De Felice, F. G. (2007) · IUBMB Life · doi:10.1080/15216540701283882 · Cited by 335 · see citing works

Activation of Wnt signaling rescues neurodegeneration and behavioral impairments induced by β-amyloid fibrils

Ferrari, G. V. D., Chacón, M. A., Barría, M. I., Garrido, J., Godoy, J. A., Olivares, G. H., Reyes, A. E., Alvarez, A. R., Bronfman, M., & Inestrosa, N. C. (2003) · Molecular Psychiatry · doi:10.1038/sj.mp.4001208 · Cited by 331 · see citing works

Resveratrol Selectively Remodels Soluble Oligomers and Fibrils of Amyloid Aβ into Off-pathway Conformers

Ladiwala, A. R. A., Lin, J. C., Bale, S. S., Marcelino, A. M. C., Bhattacharya, M., Dordick, J. S., & Tessier, P. M. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.133108 · Cited by 299 · see citing works

Dendritic Spine Loss and Synaptic Alterations in Alzheimer’s Disease

Knobloch, M., & Mansuy, I. M. (2008) · Molecular Neurobiology · doi:10.1007/s12035-008-8018-z · Cited by 296 · see citing works

Connecting TNF-α Signaling Pathways to iNOS Expression in a Mouse Model of Alzheimer's Disease: Relevance for the Behavioral and Synaptic Deficits Induced by Amyloid β Protein

Medeiros, R., Prediger, R. D. S., Passos, G. F., Pandolfo, P., Duarte, F. S., Franco, J. L., Dafre, A. L., Di Giunta, G., Figueiredo, C. P., Takahashi, R. N., et al. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.5047-06.2007 · Cited by 292 · see citing works

Activation of Wnt signaling by lithium and rosiglitazone reduced spatial memory impairment and neurodegeneration in brains of an APPswe/PSEN1ΔE9 mouse model of Alzheimer's disease

Toledo, E. M., & Inestrosa, N. C. (2009) · Molecular Psychiatry · doi:10.1038/mp.2009.72 · Cited by 290 · see citing works

Delivery of peptide and protein drugs over the blood–brain barrier

Brasnjevic, I., Steinbusch, H. W. M., Schmitz, C., & Martinez-Martinez, P. (2009) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2008.12.002 · Cited by 279 · see citing works

Neuroinflammation in Alzheimer's Disease: Mechanisms, Pathologic Consequences, and Potential for Therapeutic Manipulation

Hensley, K. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-1414 · Cited by 250 · see citing works

Chitosan nanoparticles as a new delivery system for the anti-Alzheimer drug tacrine

Wilson, B., Samanta, M. K., Santhi, K., Kumar, K. P. S., Ramasamy, M., & Suresh, B. (2009) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2009.04.001 · Cited by 245 · see citing works

Therapeutic potential of resveratrol in Alzheimer's disease

Vingtdeux, V., Dreses‐Werringloer, U., Zhao, H., Davies, P. J., & Marambaud, P. (2008) · BMC Neuroscience · doi:10.1186/1471-2202-9-s2-s6 · Cited by 224 · see citing works

Selective Synthesis and Biological Evaluation of Sulfate-Conjugated Resveratrol Metabolites

Hoshino, J., Park, E., Kondratyuk, T. P., Marler, L., Pezzuto, J. M., van Breemen, R. B., Mo, S., Li, Y., & Cushman, M. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100274c · Cited by 202 · see citing works

JNK: A Stress-Activated Protein Kinase Therapeutic Strategies and Involvement in Alzheimer’s and Various Neurodegenerative Abnormalities

Mehan, S., Meena, H., Sharma, D., & Sankhla, R. (2010) · Journal of Molecular Neuroscience · doi:10.1007/s12031-010-9454-6 · Cited by 185 · see citing works

Pleiotropic mechanisms facilitated by resveratrol and its metabolites

Calamini, B., Ratia, K. M., Malkowski, M. G., Cuendet, M., Pezzuto, J. M., Santarsiero, B. D., & Mesecar, A. D. (2010) · Biochemical Journal · doi:10.1042/bj20091857 · Cited by 176 · see citing works

Microglia Activation and Anti-inflammatory Regulation in Alzheimer’s Disease

Lue, L., Kuo, Y., Beach, T. G., & Walker, D. G. (2010) · Molecular Neurobiology · doi:10.1007/s12035-010-8106-8 · Cited by 175 · see citing works

Resveratrol and novel potent activators of SIRT1: effects on aging and age-related diseases

Knutson, M. D., & Leeuwenburgh, C. (2008) · Nutrition Reviews · doi:10.1111/j.1753-4887.2008.00109.x · Cited by 175 · see citing works

Nanotechnological applications for the treatment of neurodegenerative disorders

Modi, G., Pillay, V., Choonara, Y. E., Ndesendo, V. M. K., du Toit, L. C., & Naidoo, D. (2009) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2009.05.002 · Cited by 172 · see citing works

Characterization of trans-Resveratrol-Loaded Lipid-Core Nanocapsules and Tissue Distribution Studies in Rats

Frozza, R. L., Bernardi, A., Paese, K., Hoppe, J. B., da Silva, T., Battastini, A. M. O., Pohlmann, A. R., Guterres, S. S., & Salbego, C. G. (2010) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2010.1161 · Cited by 172 · see citing works

Glycogen synthase kinase 3β and Alzheimer’s disease: pathophysiological and therapeutic significance

Balaraman, Y., Limaye, A. R., Levey, A. I., & Srinivasan, S. (2006) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-5597-y · Cited by 167 · see citing works

Protein kinase C inhibits amyloid β‐peptide neurotoxicity by acting on members of the Wnt pathway

Garrido, J., Godoy, J. A., Alvarez, A. R., Bronfman, M., & Inestrosa, N. C. (2002) · The FASEB Journal · doi:10.1096/fj.02-0327fje · Cited by 163 · see citing works

Indomethacin-loaded nanocapsules treatment reduces in vivo glioblastoma growth in a rat glioma model

Bernardi, A., Braganhol, E., Jäger, E., Figueiró, F., Edelweiss, M. I. A., Pohlmann, A. R., Guterres, S. S., & Battastini, A. M. O. (2009) · Cancer Letters · doi:10.1016/j.canlet.2009.02.018 · Cited by 161 · see citing works

Sustained Release from Lipid-Core Nanocapsules by Varying the Core Viscosity and the Particle Surface Area

Jäger, E., Venturini, C. G., Poletto, F. S., Colomé, L. M., Pohlmann, J. P. U., Bernardi, A., Battastini, A. M. O., Guterres, S. S., & Pohlmann, A. R. (2009) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2009.1004 · Cited by 152 · see citing works

JNK Plays a Key Role in Tau Hyperphosphorylation in Alzheimer's Disease Models

Ploia, C., Antoniou, X., Sclip, A., Grande, V., Cardinetti, D., Colombo, A., Canu, N., Benussi, L., Ghidoni, R., Forloni, G., et al. (2011) · Journal of Alzheimer's Disease · doi:10.3233/jad-2011-110320 · Cited by 145 · see citing works

Effects of indomethacin‐loaded nanocapsules in experimental models of inflammation in rats

Bernardi, A., Zilberstein, A., Jäger, E., Campos, M. M., Morrone, F. B., Calixto, J. Β., Pohlmann, A. R., Guterres, S. S., & Battastini, A. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00244.x · Cited by 135 · see citing works

Animal Models of Alzheimer's Disease: Therapeutic Implications

Woodruff‐Pak, D. S. (2008) · Journal of Alzheimer s Disease · doi:10.3233/jad-2008-15401 · Cited by 133 · see citing works

Sirtuins as Novel Targets for Alzheimer's Disease and Other Neurodegenerative Disorders: Experimental and Genetic Evidence

Albani, D., Polito, L., & Forloni, G. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-1215 · Cited by 122 · see citing works

Diffusion and mathematical modeling of release profiles from nanocarriers

Cruz, L., SOARES, L., Costa, T. D., Mezzalira, G., DASILVEIRA, N., Guterres, S. S., & Pohlmann, A. R. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.01.035 · Cited by 122 · see citing works

The binding of resveratrol to monomer and fibril amyloid beta

Ge, J., Qiao, J., Qi, C., Wang, C.-W., & Zhou, J. (2012) · Neurochemistry International · doi:10.1016/j.neuint.2012.08.012 · Cited by 105 · see citing works

Phenethyl isothiocyanate exhibits antileukemic activity in vitro and in vivo by inactivation of Akt and activation of JNK pathways

Gao, N., Budhraja, A., Cheng, S., Liu, E.-H., Chen, J., Yang, Z., Chen, D., Zhang, Z., & Shi, X. (2011) · Cell Death and Disease · doi:10.1038/cddis.2011.22 · Cited by 102 · see citing works

Indomethacin-loaded lipid-core nanocapsules reduce the damage triggered by Aβ1-42 in Alzheimer’s disease models

Bernardi, A., Frozza, R. L., Meneghetti, Hoppe, Battastini, A. M. O., Pohlmann, Guterres, S. S., & Salbego (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s35333 · Cited by 90 · see citing works

Antitumor Activity of Resveratrol and its Sulfated Metabolites against Human Breast Cancer Cells

Miksits, M., Wlcek, K., Svoboda, M., Kunert, O., Haslinger, E., Thalhammer, T., Szekeres, T., & Jäger, W. R. (2009) · Planta Medica · doi:10.1055/s-0029-1185533 · Cited by 84 · see citing works

Protective effect of resveratrol against oxygen–glucose deprivation in organotypic hippocampal slice cultures: Involvement of PI3-K pathway

Zamin, L. L., Dillenburg-Pilla, P., Comiran, R. A., Horn, A. P., Simão, F., Nassif, M., Gerhardt, D., Frozza, R. L., & Salbego, C. G. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.06.002 · Cited by 81 · see citing works

WNT5A Signaling Contributes to Aβ-Induced Neuroinflammation and Neurotoxicity

Li, B., Zhong, L., Yang, X., Andersson, T., Huang, M., & Tang, S.-J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022920 · Cited by 81 · see citing works

Synaptotoxicity in Alzheimer's Disease: The Wnt Signaling Pathway as a Molecular Target

Inestrosa, N. C., Varela‐Nallar, L., Grabowski, C. P., & Colombres, M. (2007) · IUBMB Life · doi:10.1080/15216540701242490 · Cited by 65 · see citing works

Role of the Macrophage Inflammatory Protein-1α/CC Chemokine Receptor 5 Signaling Pathway in the Neuroinflammatory Response and Cognitive Deficits Induced by β-Amyloid Peptide

Passos, G. F., Figueiredo, C. P., Prediger, R. D., Pandolfo, P., Duarte, F. S., Medeiros, R., & Calixto, J. Β. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.081113 · Cited by 60 · see citing works

Neurodegenerative and physiological actions of c-Jun N-terminal kinases in the mammalian brain

Waetzig, V., & Herdegen, T. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.02.041 · Cited by 58 · see citing works

Dexamethasone-loaded nanoparticle-coated microparticles: Correlation between in vitro drug release and drug transport across Caco-2 cell monolayers

Beck, R. C. R., Pohlmann, A. R., Hoffmeister, C. R. D., Gallas, M. R., Collnot, E. M., Schaefer, U. F., Guterres, S. S., & Lehr, C. (2007) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2007.01.007 · Cited by 51 · see citing works

Influence of Benzyl Benzoate as Oil Core on the Physicochemical Properties of Spray-Dried Powders from Polymeric Nanocapsules Containing Indomethacin

Guterres, V. S. S. (2000) · Drug Delivery · doi:10.1080/107175400455119 · Cited by 51 · see citing works

Determining the simultaneous presence of drug nanocrystals in drug-loaded polymeric nanocapsule aqueous suspensions: A relation between light scattering and drug content

Pohlmann, A. R., Mezzalira, G., Venturini, C. D. G., Cruz, L., Bernardi, A., Jäger, E., Battastini, A. M. O., da Silveira, N. P., & Guterres, S. S. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.04.007 · Cited by 40 · see citing works

Alkaline Hydrolysis as a Tool to Determine the Association form of Indomethacin in Nanocapsules Prepared with Poly(ε-Caprolactone)

Pohlmann, A. R., Soares, L. U., Cruz, L., da Silveira, N. P., & Guterres, S. S. (2004) · Current Drug Delivery · doi:10.2174/1567201043479920 · Cited by 32 · see citing works

Protective effects of indomethacin-loaded nanocapsules against oxygen-glucose deprivation in organotypic hippocampal slice cultures: Involvement of neuroinflammation

Bernardi, A., Frozza, R. L., Horn, A. P., Campos, M. M., Calixto, J. Β., Salbego, C. G., Pohlmann, A. R., Guterres, S. S., & Battastini, A. M. O. (2010) · Neurochemistry International · doi:10.1016/j.neuint.2010.07.012 · Cited by 30 · see citing works

Targeted therapy in chronic diseases using nanomaterial-based drug delivery vehicles

Singh, A. P., Biswas, A., Shukla, A., & Maiti, P. (2019) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-019-0068-3 · Cited by 645 · see citing works

Drug Delivery Systems, CNS Protection, and the Blood Brain Barrier

Upadhyay, R. K. (2014) · BioMed Research International · doi:10.1155/2014/869269 · Cited by 532 · see citing works

Neuroprotective action of resveratrol

Bastianetto, S., Ménard, C., & Quirion, R. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.09.011 · Cited by 411 · see citing works

Neuroprotective Mechanisms of Resveratrol in Alzheimer’s Disease: Role of SIRT1

Gomes, B. A. Q., Silva, J. P. B., Romeiro, C. F. R., dos Santos, S. M., Rodrigues, C. A., Gonçalves, P. R., Sakai, J. T., Mendes, P. F. S., Varela, E. L. P., & Monteiro, M. C. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/8152373 · Cited by 403 · see citing works

Anti-Inflammatory Effects of Resveratrol: Mechanistic Insights

Coutinho, D. D. S., Pacheco, M. T., Frozza, R. L., & Bernardi, A. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19061812 · Cited by 298 · see citing works

Polyphenol Stilbenes: Molecular Mechanisms of Defence against Oxidative Stress and Aging-Related Diseases

Reinisalo, M., Kårlund, A., Koskela, A. K. J., Kaarniranta, K., & Karjalainen, R. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/340520 · Cited by 285 · see citing works

Neuroprotective effects of resveratrol in Alzheimer disease pathology

Rege, S. D., Geetha, T., Griffin, G. D., Broderick, T. L., & Babu, J. R. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00218 · Cited by 243 · see citing works

Brain-targeted delivery of resveratrol using solid lipid nanoparticles functionalized with apolipoprotein E

Neves, A. R., Queiroz, J. F., & Reis, S. (2016) · Journal of Nanobiotechnology · doi:10.1186/s12951-016-0177-x · Cited by 241 · see citing works

Protein Folding and Aggregation into Amyloid: The Interference by Natural Phenolic Compounds

Stefani, M., & Rigacci, S. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms140612411 · Cited by 239 · see citing works

The Link between Oxidative Stress, Mitochondrial Dysfunction and Neuroinflammation in the Pathophysiology of Alzheimer’s Disease: Therapeutic Implications and Future Perspectives

Jurcău, M. C., Andronie-Cioara, F. L., Jurcău, A., Marcu, F., Ţiț, D. M., Pașcalău, N., & Nistor-Cseppentö, D. C. (2022) · Antioxidants · doi:10.3390/antiox11112167 · Cited by 226 · see citing works

Free and nanoencapsulated curcumin suppress β-amyloid-induced cognitive impairments in rats: Involvement of BDNF and Akt/GSK-3β signaling pathway

Hoppe, J. B., Coradini, K., Frozza, R. L., de Oliveira, C. M., Meneghetti, A., Bernardi, A., Pires, E. N. S., Beck, R. C. R., & Salbego, C. G. (2013) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2013.08.001 · Cited by 207 · see citing works

Multi-Target-Directed Ligands and other Therapeutic Strategies in the Search of a Real Solution for Alzheimer’s Disease

Agis-Torres, A., Sollhuber, M., Fernandez, M., & Sanchez-Montero, J. M. (2014) · Current Neuropharmacology · doi:10.2174/1570159x113116660047 · Cited by 202 · see citing works

Co-encapsulation of resveratrol and curcumin in lipid-core nanocapsules improves their in vitro antioxidant effects

Coradini, K., Lima, F. O., Oliveira, C. M., Chaves, P. S., Athayde, M. L., Carvalho, L. M., & Beck, R. C. R. (2014) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2014.04.009 · Cited by 200 · see citing works

Autophagy inhibition improves the efficacy of curcumin/temozolomide combination therapy in glioblastomas

Zanotto‐Filho, A., Braganhol, E., Klafke, K., Figueiró, F., Terra, S. R., Paludo, F. J. D. O., Morrone, M. D. S., Bristot, I. J., Battastini, A. M. O., Forcelini, C. M., et al. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.12.044 · Cited by 197 · see citing works

Role of phenolic acid, tannins, stilbenes, lignans and flavonoids in human health – a review

OLUWOLE, O. B., Fernando, W. M. A. D. B., Lumanlan, J. C., Ademuyiwa, O. H., & Jayasena, V. (2022) · International Journal of Food Science & Technology · doi:10.1111/ijfs.15936 · Cited by 184 · see citing works

Nanoformulations of Herbal Extracts in Treatment of Neurodegenerative Disorders

Moradi, S. Z., Momtaz, S., Bayrami, Z., Farzaei, M. H., & Abdollahi, M. R. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00238 · Cited by 181 · see citing works

Resveratrol and Alzheimer’s Disease: Mechanistic Insights

Ahmed, T., Javed, S., Javed, S., Tariq, A., Šamec, D., Tejada, S., Nabavi, S. F., Braidy, N., & Nabavi, S. M. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-9839-9 · Cited by 179 · see citing works

Resveratrol Brain Delivery for Neurological Disorders Prevention and Treatment

Andrade, S., Ramalho, M. J., Pereira, M. D. C., & Loureiro, J. A. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01261 · Cited by 173 · see citing works

Molecular Mechanisms of Neuroinflammation in Aging and Alzheimer’s Disease Progression

Andronie-Cioară, F. L., Ardelean, A. I., Nistor-Cseppento, C. D., Jurcău, A., Jurcău, M. C., Pașcalău, N., & Marcu, F. M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24031869 · Cited by 164 · see citing works

Mitochondrial membrane permeabilisation by amyloid aggregates and protection by polyphenols

Camilleri, A., Zarb, C., Caruana, M., Ostermeier, U., Ghio, S., Högen, T., Schmidt, F., Giese, A., & Vassallo, N. (2013) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2013.06.026 · Cited by 161 · see citing works

Putative Role of Red Wine Polyphenols against Brain Pathology in Alzheimer’s and Parkinson’s Disease

Caruana, M., Cauchi, R. J., & Vassallo, N. (2016) · Frontiers in Nutrition · doi:10.3389/fnut.2016.00031 · Cited by 162 · see citing works

Phenolic Compounds Characteristic of the Mediterranean Diet in Mitigating Microglia-Mediated Neuroinflammation

Ortega, R. H., Cerezo, A. B., de Pablos, R. M., Krisa, S., Richard, T., García-Parrilla, M. C., & Troncoso, A. M. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00373 · Cited by 130 · see citing works

Natural Antioxidant Compounds as Potential Pharmaceutical Tools against Neurodegenerative Diseases

Marino, A., Battaglini, M., Moles, N., & Ciofani, G. (2022) · ACS Omega · doi:10.1021/acsomega.2c03291 · Cited by 132 · see citing works

Improved Neuroprotective Effects of Resveratrol-Loaded Polysorbate 80-Coated Poly(Lactide) Nanoparticles in MPTP-Induced Parkinsonism

Lindner, G. D. R., Santos, D. B., Colle, D., Moreira, E. L. G., Prediger, R. D., Farina, M., Khalil, N. M., & Mainardes, R. M. (2015) · Nanomedicine · doi:10.2217/nnm.14.165 · Cited by 126 · see citing works

Nanotechnology-based formulations for resveratrol delivery: Effects on resveratrol in vivo bioavailability and bioactivity

Paiva‐Santos, A. C., Pereira, I., Pereira‐Silva, M., Ferreira, L., Caldas, M., Collado-González, M., Magalhães, M., Figueiras, A., Ribeiro, A. J., & Veiga, F. (2019) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2019.04.030 · Cited by 121 · see citing works

Nano-antioxidants: An emerging strategy for intervention against neurodegenerative conditions

Sandhir, R., Yadav, A., Sunkaria, A., & Singhal, N. K. (2015) · Neurochemistry International · doi:10.1016/j.neuint.2015.08.011 · Cited by 119 · see citing works

Recent trends in the development of nanophytobioactive compounds and delivery systems for their possible role in reducing oxidative stress in Parkinson’s disease models

Ganesan, P., Ko, H.-M., Kim, I., & Choi, D. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s93918 · Cited by 119 · see citing works

Reactive oxygen species-scavenging nanomaterials for the prevention and treatment of age-related diseases

Dai, Y., Guo, Y., Tang, W., Chen, D., Xue, L., Chen, Y., Guo, Y., Wei, S., Wu, M., Dai, J., et al. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-02501-9 · Cited by 116 · see citing works

Natural Products as a Potential Modulator of Microglial Polarization in Neurodegenerative Diseases

Jin, X., Liu, M.-Y., Zhang, D.-F., Zhong, X., Du, K., Qian, P., Gao, H., & Wei, M.-J. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104253 · Cited by 109 · see citing works

Neuroprotective effects of curcumin lipid-core nanocapsules in a model Alzheimer’s disease induced by β-amyloid 1-42 peptide in aged female mice

Giacomeli, R., Izoton, J. C., dos Santos, R. B., Boeira, S. P., Jessé, C. R., & Haas, S. E. (2019) · Brain Research · doi:10.1016/j.brainres.2019.146325 · Cited by 108 · see citing works

Berberine was neuroprotective against an in vitro model of brain ischemia: Survival and apoptosis pathways involved

Pires, E. N. S., Frozza, R. L., Hoppe, J. B., Menezes, B. D. M., & Salbego, C. G. (2014) · Brain Research · doi:10.1016/j.brainres.2014.02.021 · Cited by 107 · see citing works

A novel approach to arthritis treatment based on resveratrol and curcumin co-encapsulated in lipid-core nanocapsules: In vivo studies

Coradini, K., Friedrich, R. B., da Fonseca, F. N., Vencato, M., de Andrade, D. F., de Oliveira, C. M., Battistel, A. P., Guterres, S. S., da Rocha, M. I. D. U. M., Pohlmann, A. R., et al. (2015) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2015.07.012 · Cited by 105 · see citing works

Therapeutic approaches against common structural features of toxic oligomers shared by multiple amyloidogenic proteins

Guerrero‐Munoz, M. J., Castillo‐Carranza, D. L., & Kayed, R. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.12.023 · Cited by 103 · see citing works

Oral Administration of Resveratrol-Loaded Solid Lipid Nanoparticle Improves Insulin Resistance Through Targeting Expression of SNARE Proteins in Adipose and Muscle Tissue in Rats with Type 2 Diabetes

Mohseni, R., Sadeghabadi, Z. A., Ziamajidi, N., Abbasalipourkabir, R., & Farimani, A. R. (2019) · Nanoscale Research Letters · doi:10.1186/s11671-019-3042-7 · Cited by 98 · see citing works

The Interaction of Polyphenols and the Gut Microbiota in Neurodegenerative Diseases

Zhang, Y., Yu, W., Zhang, L., Wang, M., & Chang, W. (2022) · Nutrients · doi:10.3390/nu14245373 · Cited by 95 · see citing works

Resveratrol induces dephosphorylation of Tau by interfering with the MID1-PP2A complex

Schweiger, S., Matthes, F., Posey, K. L., Kickstein, E., Weber, S. S., Hettich, M. M., Pfurtscheller, S., Ehninger, D., Schneider, R., & Krauß, S. (2017) · Scientific Reports · doi:10.1038/s41598-017-12974-4 · Cited by 92 · see citing works

The protective role of plant biophenols in mechanisms of Alzheimer's disease

Omar, S. H., Scott, C., Hamlin, A. S., & Obied, H. K. (2017) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2017.02.016 · Cited by 82 · see citing works

Nanotechnology Based Theranostic Approaches in Alzheimer's Disease Management: Current Status and Future Perspective

Ahmad, J., Akhter, S., Rizwanullah, M., Khan, M. A., Pigeon, L., Addo, R. T., Greig, N. H., Midoux, P., Pichon, C., & Kamal, M. A. (2017) · Current Alzheimer Research · doi:10.2174/1567205014666170508121031 · Cited by 81 · see citing works

Nanocarriers for resveratrol delivery: Impact on stability and solubility concerns

Paiva‐Santos, A. C., Pereira, I., Pereira‐Silva, M., Ferreira, L., Caldas, M., Magalhães, M., Figueiras, A., Ribeiro, A. J., & Veiga, F. (2019) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2019.07.048 · Cited by 79 · see citing works

Resveratrol: A potential therapeutic natural polyphenol for neurodegenerative diseases associated with mitochondrial dysfunction

Yadav, E., Yadav, P. S., Khan, M. M. U., Singh, H., & Verma, A. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.922232 · Cited by 81 · see citing works

Resveratrol, a natural polyphenol, prevents chemotherapy-induced cognitive impairment: Involvement of cytokine modulation and neuroprotection

Shi, D., Dong, C. M., Ho, L. C., Lam, C. T. W., Zhou, X., Wu, E. X., Zhou, Z., Wang, X., & Zhang, Z.-J. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.03.006 · Cited by 79 · see citing works

Resveratrol reduces morphine tolerance by inhibiting microglial activation via AMPK signalling

Han, Y., Jiang, C., Tang, J., Wang, C., Wu, P., Zhang, G., Liu, W., Jamangulova, N., Wu, X., & Song, X. (2014) · European Journal of Pain · doi:10.1002/ejp.511 · Cited by 77 · see citing works

Therapeutic Potential of Phytoconstituents in Management of Alzheimer’s Disease

Singh, S. P., Nand, S., Maurya, A., Mishra, G., Awasthi, R., Shakya, A., Chellappan, D. K., Dua, K., Vamanu, E., Chaudhary, S. K., et al. (2021) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2021/5578574 · Cited by 75 · see citing works

Nanotechnology to improve the Alzheimer’s disease therapy with natural compounds

Ramalho, M. J., Andrade, S., Loureiro, J. A., & do Carmo Pereira, M. (2020) · Drug Delivery and Translational Research · doi:10.1007/s13346-019-00694-3 · Cited by 75 · see citing works

Xanthoceraside Could Ameliorate Alzheimer’s Disease Symptoms of Rats by Affecting the Gut Microbiota Composition and Modulating the Endogenous Metabolite Levels

Zhou, H., Tai, J., Xu, H., Lu, X., & Meng, D. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01035 · Cited by 72 · see citing works

Nutraceuticals and amyloid neurodegenerative diseases: a focus on natural phenols

Rigacci, S., & Stefani, M. (2014) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2015.986101 · Cited by 69 · see citing works

Melatonin delivery by nanocapsules during in vitro bovine oocyte maturation decreased the reactive oxygen species of oocytes and embryos

Remião, M. H., Lucas, C. G., Domingues, W. B., da Silveira, T. L. R., Barther, N. N., Komninou, E. R., Basso, A. C., Jornada, D. S., Beck, R. C. R., Pohlmann, A. R., et al. (2016) · Reproductive Toxicology · doi:10.1016/j.reprotox.2016.05.016 · Cited by 69 · see citing works

Magnetic Resveratrol Liposomes as a New Theranostic Platform for Magnetic Resonance Imaging Guided Parkinson’s Disease Targeting Therapy

Wang, M., Li, L., Zhang, X., Liu, Y., Zhu, R., Liu, L., Fang, Y., Gao, Z., & Gao, D. (2018) · ACS Sustainable Chemistry & Engineering · doi:10.1021/acssuschemeng.8b04507 · Cited by 69 · see citing works

Nanoparticle-mediated growth factor delivery systems: A new way to treat Alzheimer's disease

Lauzon, M.-A., Daviau, A., Marcos, B., & Faucheux, N. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.03.024 · Cited by 65 · see citing works

The Tragedy of Alzheimer’s Disease: Towards Better Management via Resveratrol-Loaded Oral Bilosomes

Abbas, H., Gad, H. A., Khattab, M. A., & Mansour, M. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13101635 · Cited by 62 · see citing works

Effect of Resveratrol on Reactive Oxygen Species-Induced Cognitive Impairment in Rats with Angiotensin II-Induced Early Alzheimer’s Disease †

Lin, Y., Wu, Y., Sun, G., Ho, C., Wong, T., Lin, C., Chen, H., Yeh, T., Li, C., Tseng, C., et al. (2018) · Journal of Clinical Medicine · doi:10.3390/jcm7100329 · Cited by 60 · see citing works

Regulation of GSK-3 activity by curcumin, berberine and resveratrol: Potential effects on multiple diseases

McCubrey, J. A., Lertpiriyapong, K., Steelman, L. S., Abrams, S. L., Cocco, L., Ratti, S., Martelli, A. M., Candido, S., Libra, M., Montalto, G., et al. (2017) · Advances in Biological Regulation · doi:10.1016/j.jbior.2017.05.005 · Cited by 59 · see citing works

Trans-resveratrol Inhibits Tau Phosphorylation in the Brains of Control and Cadmium Chloride-Treated Rats by Activating PP2A and PI3K/Akt Induced-Inhibition of GSK3β

Shati, A. A., & Alfaifi, M. Y. (2018) · Neurochemical Research · doi:10.1007/s11064-018-2683-8 · Cited by 58 · see citing works

TRPM2 in the Brain: Role in Health and Disease

Sita, G., Hrelia, P., Graziosi, A., Ravegnini, G., & Morroni, F. (2018) · Cells · doi:10.3390/cells7070082 · Cited by 57 · see citing works

Genistein protects against amyloid‐beta‐induced toxicity in SH‐SY5Y cells by regulation of Akt and Tau phosphorylation

Petry, F. D. S., Coelho, B. P., Gaelzer, M. M., Kreutz, F., Guma, F. T. C. R., Salbego, C. G., & Trindade, V. M. T. (2019) · Phytotherapy Research · doi:10.1002/ptr.6560 · Cited by 57 · see citing works

Nanotechnology-based herbal medicine: Preparation, synthesis, and applications in food and medicine

Awlqadr, F. H., Majeed, K. R., Altemimi, A. B., Hassan, A. M. A., Qadir, S. A., Saeed, M. N., Faraj, A. M., Salih, T. H., Al‐Manhel, A. J. A., Najm, M. A. A., et al. (2025) · Journal of Agriculture and Food Research · doi:10.1016/j.jafr.2025.101661 · Cited by 56 · see citing works

Benefits and limitations of nanomedicine treatment of brain cancers and age-dependent neurodegenerative disorders

Неганова, М. Е., Aleksandrova, Y. R., Sukocheva, O. A., & Klochkov, S. G. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.06.011 · Cited by 56 · see citing works

Resveratrol Nanoparticles: A Promising Therapeutic Advancement over Native Resveratrol

Chung, I., Subramanian, U., Thirupathi, P., Venkidasamy, B., Samynathan, R., Gangadhar, B. H., Rajakumar, G., & Thiruvengadam, M. (2020) · Processes · doi:10.3390/pr8040458 · Cited by 51 · see citing works

α-bisabolol-loaded lipid-core nanocapsules reduce lipopolysaccharide-induced pulmonary inflammation in mice

D’Almeida, A. P. L., de Oliveira, M. P., de Souza, É., Coutinho, D. D. S., Ciambarella, B. T., Gomes, C., Terroso, T. F., Guterres, S. S., Pohlmann, A. R., Silva, P., et al. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s130798 · Cited by 50 · see citing works

Resveratrol in Alzheimer's disease: a review of pathophysiology and therapeutic potential

Sousa, J. C. E., SANTANA, A. C. F., & MAGALHÃES, G. J. P. (2020) · Arquivos de Neuro-Psiquiatria · doi:10.1590/0004-282x20200010 · Cited by 49 · see citing works

The Role of Sirtuin 1 (SIRT1) in Neurodegeneration

Razick, D., Akhtar, M., Wen, J., Alam, M., Dean, N., Karabala, M., Ansari, U., Ansari, Z., Tabaie, E. A., & Siddiqui, S. (2023) · Cureus · doi:10.7759/cureus.40463 · Cited by 48 · see citing works

Advances in Nanomedicine for the Treatment of Alzheimer’s and Parkinson’s Diseases

Hernando, S., Gartziandia, O., Herrán, E., Pedraz, J. L., Igartúa, M., & Hernández, R. M. (2016) · Nanomedicine · doi:10.2217/nnm-2016-0019 · Cited by 48 · see citing works

Impaired autophagy: a link between neurodegenerative and neuropsychiatric diseases

Polajnar, M., & Žerovnik, E. (2014) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12349 · Cited by 47 · see citing works

Neuroprotective effect of phytoconstituents via nanotechnology for treatment of Alzheimer diseases

Paramanick, D., Singh, V. D., & Singh, V. K. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.09.058 · Cited by 47 · see citing works

Resveratrol Protects Hippocampal Astrocytes Against LPS-Induced Neurotoxicity Through HO-1, p38 and ERK Pathways

Bellaver, B., de Souza, D. G., Bobermin, L. D., Souza, D. O., Gonçalves, C., & Quincozes‐Santos, A. (2015) · Neurochemical Research · doi:10.1007/s11064-015-1636-8 · Cited by 46 · see citing works

Chrysin loaded lipid-core nanocapsules ameliorates neurobehavioral alterations induced by β-amyloid1-42 in aged female mice

Giacomeli, R., de Gomes, M. G., Reolon, J. B., Haas, S. E., Colomé, L. M., & Jessé, C. R. (2020) · Behavioural Brain Research · doi:10.1016/j.bbr.2020.112696 · Cited by 46 · see citing works

Genistein attenuates amyloid-beta-induced cognitive impairment in rats by modulation of hippocampal synaptotoxicity and hyperphosphorylation of Tau

Petry, F. D. S., Hoppe, J. B., Klein, C. P., dos Santos, B. G., Hözer, R. M., Bifi, F., Matté, C., Salbego, C. G., & Trindade, V. M. T. (2020) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2020.108525 · Cited by 46 · see citing works

Alterations on Na+,K+-ATPase and Acetylcholinesterase Activities Induced by Amyloid-β Peptide in Rat Brain and GM1 Ganglioside Neuroprotective Action

Kreutz, F., Scherer, E. B. D. S., Ferreira, A. G. K., Petry, F. D. S., Pereira, C. L., Santana, F., Wyse, Â. T. D. S., Salbego, C. G., & Trindade, V. M. T. (2013) · Neurochemical Research · doi:10.1007/s11064-013-1145-6 · Cited by 44 · see citing works

Comparison of the Effect of Exercise on Late-Phase LTP of the Dentate Gyrus and CA1 of Alzheimer’s Disease Model

Dao, A. T., Zagaar, M. A., Levine, A. T., & Alkadhi, K. A. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9612-5 · Cited by 43 · see citing works

JNK Activation in Alzheimer’s Disease Is Driven by Amyloid β and Is Associated with Tau Pathology

Solas, M., Vela, S., Smerdou, C., Martišová, E., Martínez-Valbuena, I., Luquín, M. R., & Ramírez, M. J. (2023) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00093 · Cited by 42 · see citing works

Decreased Netrin-1 and Correlated Th17/Tregs Balance Disorder in Aβ1–42 Induced Alzheimer’s Disease Model Rats

Sun, L., Ju, T., Wang, T., Zhang, L., Ding, F., Zhang, Y., An, R., Sun, Y., Li, Y., Lu, Y., et al. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00124 · Cited by 42 · see citing works

Non-Enzymatic Antioxidants against Alzheimer’s Disease: Prevention, Diagnosis and Therapy

Varesi, A., Campagnoli, L. I. M., Carrara, A., Pola, I., Floris, E., Ricevuti, G., Chirumbolo, S., & Pascale, A. (2023) · Antioxidants · doi:10.3390/antiox12010180 · Cited by 45 · see citing works

Bv8/prokineticin 2 is involved in Aβ-induced neurotoxicity

Severini, C., Lattanzi, R., Maftei, D., Marconi, V., Ciotti, M. T., Passeri, P. P., Florenzano, F., DUCA, E. D., Caioli, S., Zona, C., et al. (2015) · Scientific Reports · doi:10.1038/srep15301 · Cited by 40 · see citing works

Resveratrol-loaded nanoemulsion prevents cognitive decline after abdominal surgery in aged rats

Locatelli, F. M., Kawano, T., Iwata, H., Aoyama, B., Eguchi, S., Nishigaki, A., Yamanaka, D., Tateiwa, H., Shigematsu-Locatelli, M., & Yokoyama, M. (2018) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2018.08.006 · Cited by 40 · see citing works

The role of nutrition in space exploration: Implications for sensorimotor, cognition, behavior and the cerebral changes due to the exposure to radiation, altered gravity, and isolation/confinement hazards of spaceflight

Zwart, S. R., Mulavara, A. P., Williams, T. J., George, K. A., & Smith, S. M. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.04.026 · Cited by 41 · see citing works

Eicosapentaenoic Acid-Enriched Phosphatidylcholine Mitigated Aβ1-42-Induced Neurotoxicity via Autophagy-Inflammasome Pathway

Wen, M., Ding, L., Zhang, L., Zhang, T., Yanagita, T., Wang, Y., & Xue, C. (2019) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.9b05947 · Cited by 39 · see citing works

Curcumin, Naringenin and Resveratrol from Natural Plant Products Hold Promising Solutions for Modern World Diseases – A Recent Review

Rathinavel, T., Bhuvaneswari, M., Haritha, S., Jeevarathna, S., Janani, K. S. S., & Suresh, K. (2022) · South African Journal of Botany · doi:10.1016/j.sajb.2022.06.027 · Cited by 38 · see citing works

Modulating Inflammation-Mediated Diseases via Natural Phenolic Compounds Loaded in Nanocarrier Systems

Rakotondrabe, T. F., Fan, M., Muema, F. W., & Guo, M. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15020699 · Cited by 37 · see citing works

Glia and TRPM2 Channels in Plasticity of Central Nervous System and Alzheimer’s Diseases

Wang, J., Jackson, M. F., & Xie, Y. (2016) · Neural Plasticity · doi:10.1155/2016/1680905 · Cited by 35 · see citing works

New insights in drug development for Alzheimer's disease based on microglia function

Qiao, O., Ji, H., Zhang, Y., Zhang, X., Zhang, X., Liu, N., Huang, L., Liu, C., & Gao, W. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111703 · Cited by 34 · see citing works

Targeted Intracellular Delivery of Resveratrol to Glioblastoma Cells Using Apolipoprotein E-Containing Reconstituted HDL as a Nanovehicle

Kim, S. H., Adhikari, B. B., Cruz, S., Schramm, M. P., Vinson, J. A., & Narayanaswami, V. (2015) · PLoS ONE · doi:10.1371/journal.pone.0135130 · Cited by 33 · see citing works

Systems‐level thinking for nanoparticle‐mediated therapeutic delivery to neurological diseases

Curtis, C., Zhang, M., Liao, R., Wood, T. R., & Nance, E. A. (2016) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1422 · Cited by 32 · see citing works

Evaluation of novel conjugated resveratrol polymeric nanoparticles in reduction of plasma degradation, hepatic metabolism and its augmentation of anticancer activity in vitro and in vivo

Yee, Y. J., Benson, H. A., Dass, C. R., & Chen, Y. (2022) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2022.121499 · Cited by 32 · see citing works

Targeting the central nervous system: From synthetic nanoparticles to extracellular vesicles—Focus on Alzheimer's and Parkinson's disease

Hernando, S., Santos‐Vizcaíno, E., Igartúa, M., & Hernández, R. M. (2023) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1898 · Cited by 32 · see citing works

A comparative study of eicosapentaenoic acid enriched phosphatidylcholine and ethyl ester in improving cognitive deficiency in Alzheimer's disease model rats

Wen, M., Ding, L., Zhang, L., Cong, P., Zhang, T., Xu, J., Chang, Y., Wang, Y., & Xue, C. (2018) · Food & Function · doi:10.1039/c7fo01815k · Cited by 31 · see citing works

Nerolidol-loaded nanospheres prevent behavioral impairment via ameliorating Na+, K+-ATPase and AChE activities as well as reducing oxidative stress in the brain of Trypanosoma evansi-infected mice

Baldissera, M. D., Souza, C. F., Grando, T. H., Moreira, K. L. S., Schafer, A. S., Cossetin, L. F., da Silva, A. P. T., da Veiga, M. L., da Rocha, M. I. D. U. M., Stefani, L. M., et al. (2016) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-016-1313-8 · Cited by 30 · see citing works

Possible neuromodulating role of different grape (Vitis vinifera L.) derived polyphenols against Alzheimer’s dementia: treatment and mechanisms

Fouad, G. I., & Rizk, M. Z. (2019) · Bulletin of the National Research Centre/Bulletin of the National Research Center · doi:10.1186/s42269-019-0149-z · Cited by 29 · see citing works

Neuroprotection of resveratrol against neurotoxicity induced by methamphetamine in mouse mesencephalic dopaminergic neurons

Sun, D. I., Yue, Q., Guo, W., Li, T., Zhang, J., Li, G., Liu, Z., & Sun, J. (2015) · BioFactors · doi:10.1002/biof.1221 · Cited by 26 · see citing works

Therapeutic nanotechnologies for Alzheimer’s disease: A critical analysis of recent trends and findings

Delbreil, P., Rabanel, J., Banquy, X., & Brambilla, D. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114397 · Cited by 25 · see citing works

Agrimonia pilosa Ledeb., Cinnamomum cassia Blume, and Lonicera japonica Thunb. protect against cognitive dysfunction and energy and glucose dysregulation by reducing neuroinflammation and hippocampal insulin resistance in β-amyloid-infused rats

Park, S., Kang, S., Kim, D. S., & Moon, B. R. (2016) · Nutritional Neuroscience · doi:10.1080/1028415x.2015.1135572 · Cited by 24 · see citing works

Resveratrol targeting tau proteins, amyloid‐beta aggregations, and their adverse effects: An updated review

Ashrafizadeh, M., Zarrabi, A., Najafi, M., Samarghandian, S., Mohammadinejad, R., & Ahn, K. S. (2020) · Phytotherapy Research · doi:10.1002/ptr.6732 · Cited by 24 · see citing works

Ways to enhance the bioavailability of polyphenols in the brain: A journey through the blood-brain barrier

Zhang, Y., Lv, C., & Zhao, G. (2021) · Food Reviews International · doi:10.1080/87559129.2021.1888973 · Cited by 23 · see citing works

Coadministration of Resveratrol and Rice Oil Mitigates Nociception and Oxidative State in a Mouse Fibromyalgia-Like Model

Klein, C. P., Cintra, M. R., Binda, N. S., Diniz, D. M., Gomez, M. V., Souto, A. A., & de Souza, A. H. (2016) · Pain Research and Treatment · doi:10.1155/2016/3191638 · Cited by 23 · see citing works

Nanobiotechnology in Neurodegenerative Diseases

Jampílek, J., Kráľová, K., Novák, P., & Novák, M. (2019) · Springer eBooks · doi:10.1007/978-3-030-30930-5_4 · Cited by 22 · see citing works

Pomegranate as a natural source of phenolic antioxidants: a review

de Oliveira, F. L., Arruda, T. Y. P., Lima, R. D. S., Casarotti, S. N., & Morzelle, M. C. (2020) · Journal of Food Bioactives · doi:10.31665/jfb.2020.9214 · Cited by 22 · see citing works

A Self-Microemulsifying Formulation of Oxyresveratrol Prevents Amyloid Beta Protein-Induced Neurodegeneration in Mice

Sangsen, Y., Sooksawate, T., Likhitwitayawuid, K., Sritularak, B., & Wiwattanapatapee, R. (2018) · Planta Medica · doi:10.1055/s-0043-125337 · Cited by 21 · see citing works

Food to medicine transformation of stilbenoid vesicular and lipid-based nanocarriers: Technological advances

Samie, S. M. A., & Nasr, M. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-821222-6.00011-7 · Cited by 20 · see citing works

Phytonanomedicines, a state-of-the-art strategy for targeted delivery of anti-inflammatory phytochemicals: A review of improved pharmacokinetic profile and therapeutic efficacy

Hussain, Z., Thu, H. E., Khan, S., Sohail, M. F., Sarfraz, R. M., Mahmood, A., & Abourehab, M. A. S. (2022) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2022.103895 · Cited by 20 · see citing works

Neuroprotective Effects of Curcumin-Loaded Emulsomes in a Laser Axotomy-Induced CNS Injury Model

Yılmaz, E. N., Bay, S., Öztürk, G., & Üçışık, M. H. (2020) · International Journal of Nanomedicine · doi:10.2147/ijn.s272931 · Cited by 20 · see citing works

Update on Therapeutic potential of emerging nanoformulations of phytocompounds in Alzheimer's and Parkinson's disease

Kanojia, N., Thapa, K., Kaur, G., Sharma, A., Puri, V., & Verma, N. (2022) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2022.104074 · Cited by 19 · see citing works

P1‐006: Incorporation of resveratrol into lipid‐core nanocapsules improves its cerebral bioavailability and reduces the Aβ‐induced toxicity

Frozza, R. L., Salbego, C. G., Bernardi, A., Hoppe, J. B., Meneghetti, A., Battastini, A. M. O., Guterres, S. S., & Pohlmann, A. R. (2011) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2011.05.286 · Cited by 10 · see citing works

Lipid-Core Nanocapsules Improve the Effects of Resveratrol Against Aβ-Induced Neuroinflammation

Frozza, R. L., Bernardi, A., Hoppe, J. B., Meneghetti, A., Battastini, A. M. O., Pohlmann, A. R., Guterres, S. S., & Salbego, C. G. (2013) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2013.1709 · Cited by 70 · see citing works

Resveratrol : incorporação em nanocápsulas e neuroproteção na toxicidade induzida pelo peptídeo β-amilóide

Frozza, R. L. (2012) · Americanae (AECID Library)

Brain targeting based nanocarriers loaded with resveratrol in Alzheimer's disease: A review

Jalili, C., Kiani, A., Gholami, M., Bahrehmand, F., Fakhri, S., Kakehbaraei, S., & Kakebaraei, S. (2023) · IET Nanobiotechnology · doi:10.1049/nbt2.12127 · Cited by 42 · see citing works

Neuroprotective effects of resveratrol in Alzheimer rsquo s disease

Murlimanju, B. V. (2019) · Frontiers in Bioscience-Elite · doi:10.2741/e863 · Cited by 67 · see citing works